Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial"

Richard G. Bach, Maria Mori Brooks, Manuel Lombardero, Saul Genuth, Thomas W. Donner, Alan Garber, Laurence Kennedy, E. Scott Monrad, Rodica Pop-Busui, Sheryl F. Kelsey, Robert L. Frye

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
JournalCirculation
Volume129
Issue number16
DOIs
StatePublished - Apr 22 2014

Fingerprint

rosiglitazone
Thiazolidinediones
Angioplasty
Hypoglycemic Agents
Coronary Artery Bypass
Type 2 Diabetes Mellitus
Coronary Artery Disease
Diabetes Mellitus
Myocardial Infarction

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial". / Bach, Richard G.; Brooks, Maria Mori; Lombardero, Manuel; Genuth, Saul; Donner, Thomas W.; Garber, Alan; Kennedy, Laurence; Monrad, E. Scott; Pop-Busui, Rodica; Kelsey, Sheryl F.; Frye, Robert L.

In: Circulation, Vol. 129, No. 16, 22.04.2014.

Research output: Contribution to journalArticle

Bach, Richard G. ; Brooks, Maria Mori ; Lombardero, Manuel ; Genuth, Saul ; Donner, Thomas W. ; Garber, Alan ; Kennedy, Laurence ; Monrad, E. Scott ; Pop-Busui, Rodica ; Kelsey, Sheryl F. ; Frye, Robert L. / Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial". In: Circulation. 2014 ; Vol. 129, No. 16.
@article{09117a7a41424dac9f4bfe68c660486a,
title = "Response to letter regarding article, {"}rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial{"}",
author = "Bach, {Richard G.} and Brooks, {Maria Mori} and Manuel Lombardero and Saul Genuth and Donner, {Thomas W.} and Alan Garber and Laurence Kennedy and Monrad, {E. Scott} and Rodica Pop-Busui and Kelsey, {Sheryl F.} and Frye, {Robert L.}",
year = "2014",
month = "4",
day = "22",
doi = "10.1161/CIRCULATIONAHA.113.008033",
language = "English (US)",
volume = "129",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "16",

}

TY - JOUR

T1 - Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial"

AU - Bach, Richard G.

AU - Brooks, Maria Mori

AU - Lombardero, Manuel

AU - Genuth, Saul

AU - Donner, Thomas W.

AU - Garber, Alan

AU - Kennedy, Laurence

AU - Monrad, E. Scott

AU - Pop-Busui, Rodica

AU - Kelsey, Sheryl F.

AU - Frye, Robert L.

PY - 2014/4/22

Y1 - 2014/4/22

UR - http://www.scopus.com/inward/record.url?scp=84899108231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899108231&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.113.008033

DO - 10.1161/CIRCULATIONAHA.113.008033

M3 - Article

VL - 129

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 16

ER -